Forte Biosciences
Presence
Forte Biosciences is a company listed under the stock ticker FBRX (US).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Forte Biosciences
- Paul Wagner, Chief Executive Officer, President and Chairman of th...
- Stephen Doberstein, Director
- Steven Kornfeld, Director
Create your alert
to follow the executive moves at Forte Biosciences.
Biotechnology
Forte Biosciences has 2,285 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Forte Biosciences
- Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
- Forte Biosciences Inc - Investor Relations - News
- Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
- Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
- Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
- Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
- Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
- Mr. David Gryska Appointed to Forte Biosciences Board of Directors
- Forte Biosciences Inc - Investor Relations - News
- Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
- View more press releases Close
Social media about Forte Biosciences
- Forte Biosciences on Wikipedia, Google News & Yahoo Finance
- Forte Biosciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Lawrence Eichenfield 
Call Forte Biosciences at +1 858...
